This table presents recent patent oppositions filed by Hamm&wittkopp Patentanwalte Partmbb against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP4159204Novel Pharmaceutical CompositionNOVARTIS AGNov 11, 2024
EP4159205Novel Pharmaceutical CompositionNOVARTIS AGNov 11, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM INTERNATIONAL GMBHOct 16, 2024
EP4025188Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICA NVOct 9, 2024
EP4025187Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICA NVOct 4, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 11, 2024
EP3782612Oral Formulations Of Cytidine Analogs And Methods Of Use ThereofCELGENE CORPORATIONJul 30, 2024
EP3761949Sunscreen With A Reduced Tendency To Stain Textiles, Containing Hydrogenated Vegetable Oil And Bis-Ethylhexyloxyphenol Methoxyphenyl TriazineBEIERSDORF AGJul 17, 2024
EP3626270New UseNOVARTIS AGJul 5, 2024
EP3634463Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALS INC.Jun 26, 2024